BioPharmX (BPMX) Stock Soars on Potential 'Breakthrough' Acne Treatment
It's nice to reminisce!
BioPharmX Corp. (BPMX) stock is popping by 20.45% to $2.12 on heavy trading volume on Monday, after the pharmaceutical company announced that it may have developed a breakthrough treatment for acne.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.